Drug Trial Radar · NCT05232916
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
Last checked: Nov 19, 2026Latest source record: Aug 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
2,250
Planned (sponsor's estimate)
Start
Dec 16, 2022
Primary completion
Dec 2031
Study completion Dec 2031
Sponsor
- Lead sponsor
- Greenwich LifeSciences, Inc.Industry
- Sponsor type
- Industry
- First posted
- Feb 10, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 100 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a prospective, randomized, double-blinded, placebo-controlled, multi-center, Phase 3 study of GLSI-100 immunotherapy in HLA-A\*02 positive and HER2/neu positive subjects who are at high risk for disease recurrence and have completed both neoadjuvant and postoperative adjuvant standard of care therapy. Treatment consists of 6 intradermal injections, Primary Immunization Series (PIS), over the first 6 months of treatment and 5 booster intradermal injections spaced 6 months apart. A third open-label arm will explore GLSI-100 immunotherapy in non-HLA-A\*02 positive and HER2/neu positive subjects.
Conditions
- Breast Cancer
Interventions
PlaceboBiological
0.9% Normal Saline
GLSI-100Biological
500 mcg/mL GP2 and 125 mcg/mL GM-CSF
Primary outcomes
What the sponsor says the trial is designed to measure.
- Invasive Breast Cancer-free Survival (IBCFS)Time frame: Median 4 years of follow-up (interim analyses planned)
Locations
179 sites in 10 countries. Site status is shown where the registry gives one.
Southern Cancer Center
Mobile, Alabama · Not yet recruiting
City of Hope - Cancer Center Phoenix
Goodyear, Arizona · Recruiting
Tucson Medical Center HealthCare
Tucson, Arizona · Recruiting
City of Hope - Duarte Cancer Center
Duarte, California · Recruiting
Providence St. Jude Medical Center - Virginia K. Crosson Cancer Center
Fullerton, California · Recruiting
City of Hope - Orange County Lennar Foundation Cancer Center
Irvine, California · Recruiting
University of California San Diego - Moores Cancer Center
La Jolla, California · Recruiting
University of Southern California - Norris Comprehensive Cancer Center
Los Angeles, California · Active not recruiting
Stanford Medicine Cancer Center - Stanford Women's Cancer Center
Palo Alto, California · Recruiting
University of California San Francisco - Helen Diller Family Comprehensive Cancer Center
San Francisco, California · Recruiting
University of California Los Angeles - Hematology / Oncology Parkside
Santa Monica, California · Recruiting
PIH Health Hospital - Whittier Hospital
Whittier, California · Recruiting
Rocky Mountain Cancer Centers
Denver, Colorado · Recruiting
Yale Cancer Center - Smilow Cancer Hospital
New Haven, Connecticut · Recruiting
Johns Hopkins Medicine - Kimmel Cancer Center-Sibley Memorial Hospital
Washington D.C., District of Columbia · Recruiting
University of Miami - Sylvester Comprehensive Cancer Center
Miami, Florida · Recruiting
Moffitt Cancer Center
Tampa, Florida · Recruiting
City of Hope - Cancer Center Atlanta
Newnan, Georgia · Recruiting
Northwestern University - Northwestern Memorial Hospital
Chicago, Illinois · Recruiting
City of Hope - Cancer Center Chicago
Zion, Illinois · Recruiting
Maryland Oncology Hematology
Annapolis, Maryland · Recruiting
Massachusetts General Hospital Cancer Center
Boston, Massachusetts · Recruiting
Minnesota Oncology
Maple Grove, Minnesota · Recruiting
Siteman Cancer Center - Washington University Medical Campus
St Louis, Missouri · Recruiting
Nebraska Cancer Specialists
Omaha, Nebraska · Recruiting
Nebraska Medicine - University of Nebraska Medical Center
Omaha, Nebraska · Recruiting
Comprehensive Cancer Centers of Nevada
Henderson, Nevada · Recruiting
Cooper University Health Care
Camden, New Jersey · Active not recruiting
New York Oncology Hematology
Albany, New York · Recruiting
New York-Presbyterian - Columbia University Irving Medical Center
New York, New York · Recruiting
Stony Brook University Cancer Center
Stony Brook, New York · Recruiting
Oncology Hematology Care
Cincinnati, Ohio · Recruiting
Hematology Oncology Associates
Medford, Oregon · Not yet recruiting
Compass Oncology - Northwest Cancer Specialists
Tigard, Oregon · Recruiting
Redeemer Health - Holy Redeemer Hospital
Meadowbrook, Pennsylvania · Recruiting
Sidney Kimmel Comprehensive Cancer Center - Thomas Jefferson University Hospital
Philadelphia, Pennsylvania · Recruiting
Tennessee Cancer Specialists
Knoxville, Tennessee · Not yet recruiting
SCRI Oncology Partners
Nashville, Tennessee · Not yet recruiting
Texas Oncology - Austin
Austin, Texas · Recruiting
Texas Oncology - Dallas Presbyterian Hospital
Dallas, Texas · Recruiting
Showing 40 of 179 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.